Sean McWilliams, MD
Otolaryngology · Destin, FLNPI 1003854803
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (59.8%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Spirair, Inc. accounts for 61.1% of it on its own, with 5 other manufacturers making up the rest.
Across 34 payments — averaging $155.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Spirair, Inc.$3K
- Medtronic$2K
- Sanofi$131
- Regeneron Healthcare Solutions, Inc.$88
- Amgen$34
- AstraZeneca$17
Across 1 payment — averaging $24,299 each. An ownership or investment interest held by the physician or an immediate family member.
- Spirair, Inc.$24K
What the payments were for
- Consulting fees$3,15860%
- Travel & lodging$99019%
- Food & beverage$1,10021%
- Education$341%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Spirair, Inc. | 2 | $3,226 |
| Medtronic | 20 | $1,788 |
| Sanofi | 7 | $131 |
| Regeneron Healthcare Solutions, Inc. | 3 | $88 |
| Amgen | 1 | $34 |
| AstraZeneca | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,282 in reported general payments places this provider in the 80th percentile of 586 otolaryngology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Azelastine Hcl | 56 | $2,122 |
| Montelukast Sodium | 107 | $1,236 |
| Fluticasone Propionate | 49 | $1,086 |
| Ipratropium Bromide | 39 | $908 |
| Cefdinir | 27 | $702 |
| Mupirocin | 27 | $256 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 16 | $186 |
| Ondansetron OdtOndansetron | 22 | $169 |
| Methylprednisolone | 28 | $134 |
| Cephalexin | 17 | $119 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 21 | $86 |
| Azithromycin | 19 | $47 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in Destin
- Cecelia DamaskOrlando$707K
- Ralph TufanoSarasota$469K
- Franklin RimellFort Myers$314K
- David BrodnerBoynton Beach$209K
- Maria SuurnaMiami$189K
- Jane DillonOrmond Beach$180K
- Jeb JusticeGainesville$142K
- Indranil DebnathWinter Park$109K
- Agustin ArrietaMiami$95K
- John WestineGainesville$86K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.